Dr. Muthiah Vaduganathan presents Practical Guide to Implementation of SGLT2i in Clinical Practice.

(41:4)

NephroWorldCup 2022: Metformin or SGLT2i in CKD patients with Diabetes

(5:8)

ESC 2022: The EMPEROR-POOLED Trial: Clinical Benefits of SGLT2i in Heart Failure | Dr Faiez Zannad

(4:45)

The serendipitous story of SGLT2i in the treatment of heart failure

(51:52)

How does Dapagliflozin work? Understanding SGLT2 inhibitors.

(6:57)

What are SGLT2 inhibitors - Chronic Kidney Disease | UHL NHS Trust

(3:23)

Breaking News: SGLT2i in ACUTE Heart Failure

(3:44)

Role of SGLT2i in HFpEF and Its Impact on Renal Outcomes

(1:3:43)

Trilogue Symposium: Role of SGLT2i in Cardio-Renal Continuum

(2:5:37)

How SGLT2 Inhibitors Protect The Kidney

(16:24)

SGLT2i in different patient groups: effect on CKD progression | Natalie Staplin, PhD

(29:46)

SGLT2 Inhibitors in Chronic Kidney Disease

(9:6)

SGLT2 Inhibitors in Acute Heart Failure The Earlier The Better DICTATE AHF

(11:50)

SGLT2 Inhibitors Mechanism of Action

(1:44)

Dr Julie Lovshin - SGLT2i Cardiorenal mechanisms in diabetes and beyond - summary presentation

(8:32)

SGLT2 Inhibitors(SGLT2I):-The Power of SGLT2I in Cardiac Care\

(14:10)

SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease

(1:55)

Why SGLT2 Inhibitors Cause Euglycemic DKA

(11:1econd)

Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'

(35:24)

Are there alternative mechanisms to explain SGLT2i beneficial CVeffects in some patients?

(27:44)